Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 82.38M P/E - EPS this Y 33.30% Ern Qtrly Grth -
Income -11.86M Forward P/E -6.54 EPS next Y - 50D Avg Chg 1.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg 1.00%
Dividend N/A Price/Book N/A EPS next 5Y - 52W High Chg -11.00%
Recommedations 2.00 Quick Ratio 3.73 Shares Outstanding 13.71M 52W Low Chg 11.00%
Insider Own 39.13% ROA -54.58% Shares Float 6.87M Beta -
Inst Own 10.81% ROE -261.36% Shares Shorted/Prior 25.80K/14.55K Price 6.02
Gross Margin - Profit Margin - Avg. Volume 121,382 Target Price -
Oper. Margin - Earnings Date - Volume 8,515 Change 0.00%
About Intensity Therapeutics, Inc.

Intensity Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of cancer drugs in the United States. Its lead product candidate includes INT230-6, which is in human clinical studies for the treatment of refractory solid tumors, such as soft tissue sarcoma which is in phase 3 trails; and neoadjuvant and metastatic triple negative breast cancer which is in Phase 2 clinical trials. The company was incorporated in 2012 and is headquartered in Shelton, Connecticut.

Intensity Therapeutics, Inc. News
04/02/24 Intensity Therapeutics to Participate in the LD Micro Invitational XIV Conference April 8 - 9, 2024
03/26/24 Portage Biotech Completes Monetization of Intensity Therapeutics (INTS) shares
03/14/24 Intensity Therapeutics Reports Full Year 2023 Financial Results and Provides Corporate Update
03/14/24 Intensity Therapeutics to Participate in the 36th Annual Roth Conference March 17 to 19, 2024
02/21/24 Intensity Therapeutics to Present at the 2024 BIO CEO & Investor Conference
01/03/24 Intensity Therapeutics Provides Business Update Reflecting Progress in Phase 3 Sarcoma Program
12/29/23 Intensity Therapeutics (NASDAQ:INTS) Is In A Good Position To Deliver On Growth Plans
12/12/23 Intensity Therapeutics Appoints Joseph Talamo, CPA, as Chief Financial Officer
12/08/23 Intensity Therapeutics Presents Positive INT230-6 Data in Patients with Early-Stage Breast Cancer in a Podium Poster Spotlight Discussion at the 2023 SABCS
12/01/23 Intensity Therapeutics Selected for Spotlight Oral Presentation at the 2023 San Antonio Breast Cancer Symposium
11/13/23 Intensity Therapeutics Reports Third Quarter Financial Results and Provides Corporate Update
11/02/23 Intensity Therapeutics Presents Positive INT230-6 Data in Patients with Refractory Soft Tissue Sarcoma at the Connective Tissue Oncology Society Annual Meeting 2023
09/07/23 Intensity Therapeutics Receives Orphan Drug Designation for the three key ingredients in INT230-6 for the Treatment of Soft Tissue Sarcoma
09/05/23 Intensity Therapeutics to Present at the H.C. Wainwright 25th Annual Global Investment Conference
08/14/23 Intensity Therapeutics Reports Second Quarter Financial Results and Provides Corporate Update
08/07/23 Intensity Therapeutics to Announce Financial Results for the Second Quarter Ended June 30, 2023, and Provide Corporate Update
07/31/23 Portage Biotech Reports Fiscal Year-Ended March 31, 2023 Financial Results and Business Update
07/10/23 Intensity Therapeutics, Inc. Announces the Closing and Full Exercise of the Over-Allotment Option from its Upsized Initial Public Offering, Raising a Total of $22.425 Million in Gross Proceeds
07/05/23 Intensity Therapeutics, Inc. Announces Closing of Upsized Initial Public Offering, Raising Approximately $19.5 Million in Gross Proceeds
06/29/23 Intensity Therapeutics, Inc. Announces Pricing of Upsized Initial Public Offering, Raising Approximately $19.5 Million in Gross Proceeds
INTS Chatroom

User Image Flowjob Posted - 2 days ago

$PRTG Abstract out presenting interim data at #ASCO24 expecting an announcement soon, At all time lows with recent non dilutive funding by selling $INTS stake 2.5M cash and collaboration with Merck. Like the R/R https://meetings.asco.org/abstracts-presentations/235338

User Image JSTJ Posted - 1 week ago

$INTS Losing hope a bit here. Please convince me otherwise 🥴

User Image jvitalis Posted - 2 weeks ago

$INTS Good day today, everyone holding on their stocks. LIkely more good news coming.

User Image Ianwalsh15 Posted - 3 weeks ago

$INTS

User Image Ianwalsh15 Posted - 3 weeks ago

$INTS

User Image Stock_Titan Posted - 3 weeks ago

$INTS Intensity Therapeutics to Participate in the LD Micro Invitational XIV Conference April 8 - 9, 2024 https://www.stocktitan.net/news/INTS/intensity-therapeutics-to-participate-in-the-ld-micro-invitational-lvybhp16329t.html

User Image jvitalis Posted - 1 month ago

$INTS Expect to see a big run to $15 tomorrow.

User Image jvitalis Posted - 1 month ago

$INTS Looks like more good news coming...

User Image Money_never_sleep Posted - 1 month ago

$INTS

User Image jvitalis Posted - 1 month ago

$INTS https://www.tradingview.com/news/DJN_DN20240321006787:0/

User Image jvitalis Posted - 1 month ago

$INTS Intensity Therapeutics Price Target Maintained With a $12.00/Share by Benchmark

User Image _StockTrader Posted - 1 month ago

Real-Time Stock Data $INTS Price: 5.2 Volume: 29570 Market Cap: 72659824 PE Ratio: -7.910448 Powered by: OZSC

User Image Rotarypower1972 Posted - 1 month ago

$INTS lets goooooooo

User Image _StockTrader Posted - 1 month ago

Real-Time Stock Data $INTS Price: 5.2 Volume: 74820 Market Cap: 69917936 PE Ratio: -7.61194 Powered by: AITX

User Image jvitalis Posted - 1 month ago

$INTS Let go 100% today, great news!

User Image DonCorleone77 Posted - 1 month ago

$INTS Intensity Therapeutics says cash sufficient to fund operations through 1Q25 As of December 31, 2023, cash, cash equivalents and marketable debt securities totaled $14.8M, which the company expects will be sufficient to fund operations through the end of the first quarter in 2025. "We had a pivotal year in 2023 culminating with the receipt of an FDA 'Study May Proceed' letter to enter into Phase 3 clinical trials for our lead drug candidate, INT230-6 for metastatic soft tissue sarcoma," said Lewis Bender, Founder, President and CEO. "Our selection this year by the review committees at ASCO, CTOS and SABCS, including oral podium presentations, validated our science and indicated interest by oncologists in our results. We are on track to initiate our Phase 3 sarcoma study in mid-2024. Following our IPO, our cash position remains strong, and we believe we have sufficient runway to meet near term milestones."

User Image Stock_Titan Posted - 1 month ago

$INTS Intensity Therapeutics Reports Full Year 2023 Financial Results and Provides Corporate Update https://www.stocktitan.net/news/INTS/intensity-therapeutics-reports-full-year-2023-financial-results-and-1anjawh01u35.html

User Image Stock_Titan Posted - 1 month ago

$INTS Intensity Therapeutics to Participate in the 36th Annual Roth Conference March 17 to 19, 2024 https://www.stocktitan.net/news/INTS/intensity-therapeutics-to-participate-in-the-36th-annual-roth-mwoterz3pxkl.html

User Image Ianwalsh15 Posted - 1 month ago

$INTS cup n handle comin

User Image Rotarypower1972 Posted - 1 month ago

$INTS WTF happened........

User Image lithiumfreak Posted - 1 month ago

$INTS any updates?

User Image Thinklikethecompany Posted - 1 month ago

$INTS shhhh, like November, just let it ride...

User Image _StockTrader Posted - 1 month ago

Real-Time Stock Data $INTS Price: 5.29 Volume: 210083 Market Cap: 75936368 PE Ratio: -8.267164 Stock data provided by: PSYC

User Image VrtcIl Posted - 1 month ago

Trail your stops on $INTS to secure profits. Consider strategic placement below prior pivot lows on the technical chart to secure gains and manage potential downside risks effectively. Price: 5.8 Float: 8.1M Short Float: 1.2 % 💰 Dollar Volume: 17.3K ℹ️ USA | Biotechnology

User Image DekDougan Posted - 1 month ago

$PRTG 8% ownership of $INTS is worth $6million that is currently covering over 50% of $PRTG market cap. $INTS mooning today

User Image Z_interceptor Posted - 1 month ago

$INTS -> still has a lot to go . . . next $MGIH - > to $4

User Image Eroc Posted - 1 month ago

$INTS another solid day!

User Image Ianwalsh15 Posted - 1 month ago

$INTS 🧏🏻‍♂️☘️🤫

User Image Ninja_Tradez Posted - 1 month ago

$INTS You see why Ninja Bot Alerts are Import to get early ! Never Miss any alert 🚨Check Discord Link 🔗 on bio

User Image Eroc Posted - 1 month ago

$BBAI hey BBAI friends, look at another hot mover with $INTS not same world or anything, but another big mover like $BBAI. bullish on both!

Analyst Ratings
Benchmark Speculative Buy Mar 21, 24
Benchmark Speculative Buy Nov 14, 23
Benchmark Speculative Buy Aug 24, 23
Benchmark Speculative Buy Jul 18, 23